Corporate news

Grifols agrees to acquire a 517,000 sq ft plot of land to expand its production facilities in Barcelona, Spain The plot is located in the Spanish town of Lliçà de Vall, a future industrial park adjacent to the industrial park of Llevant of Parets del Vallès, where currently Grifols has production facilities
+ info

Pedigri®: the tool that increases the information transparency to the plasma-derived manufactured in Clayton GammaSTAN®, Gamunex® / Gamunex-C®, HyperHEP B®, HyperRAB®, HyperRHO®, HyperTET®, Koāte® DVI, Plasbumin®, Prolastin® / Prolastin® C and Thrombate® III are the newly added products
+ info

Award Winners of the 9th Annual Martín Villar Haemostasis Awards Created in 2007, the awards recognize the progress made in the field of Hemostasis. The awards are endowed with 20,000 euros for each of the two prizes: Basic Research and Clinical Research.
+ info



We are a solid company with an international dimension.

Corporate Commitment

We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.

When a Dream Comes True. An Illustrated History of 75 Years of Grifols

Read When a Dream Comes True: An illustrated history of 75 years of Grifols to discover the company's roots, and learn more about our history and the development of the company.  + info


get to know us better